Stay updated on KSI-301 vs Aflibercept in Wet AMD Clinical Trial
Sign up to get notified when there's something new on the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page.

Latest updates to the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedNew revision tag v3.4.2 appears and the site-wide funding notice was removed; no trial data or user actions were affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check20 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH operations. Updated the site version from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check28 days agoChange DetectedAdded a glossary toggle and updated metadata labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'), while removing earlier labels ('Last Update Submitted that met QC Criteria', 'No FEAR Act data', 'Revision: v3.3.4').SummaryDifference0.1%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No study content or user-facing information appears to be changed.SummaryDifference0.0%

- Check63 days agoChange DetectedA new 'Locations' section with state listings was added; individual state location subsections and the HHS Vulnerability Disclosure section were removed.SummaryDifference2%

- Check91 days agoChange DetectedRevision: v3.3.2 has been added and Revision: v3.2.0 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to KSI-301 vs Aflibercept in Wet AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page.